Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)

China flag China · Delayed Price · Currency is CNY
10.82
-0.20 (-1.81%)
Apr 9, 2026, 3:00 PM CST
Market Cap4.75B +13.8%
Revenue (ttm)1.68B -4.5%
Net Income295.36M +8.2%
EPS0.67 +10.7%
Shares Out439.08M
PE Ratio16.15
Forward PE15.57
Dividend0.25 (2.27%)
Ex-Dividend DateJan 16, 2026
Volume9,843,600
Average Volume8,273,369
Open10.97
Previous Close11.02
Day's Range10.76 - 11.10
52-Week Range8.47 - 13.50
Beta0.45
RSI40.46
Earnings DateApr 25, 2026

About SHA:603998

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, gynecological drugs, and anti-infective drugs. The company's main products include Xuesetong dispersible tablets, Xuesetong tablets, Garcinia bone-strengthening tablets, Dieda Huoxue ca... [Read more]

Sector Healthcare
Founded 2002
Employees 1,807
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603998
Full Company Profile

Financial Performance

In 2024, SHA:603998's revenue was 1.78 billion, an increase of 9.15% compared to the previous year's 1.63 billion. Earnings were 255.22 million, an increase of 36.61%.

Financial Statements